Related to Transgene and Vivalis to Evaluate MVA Vaccine Production in EB66 Duck Stem Cell Line

• Scientists Create Insect-Cell Approach to Produce Swine Flu Vaccines
  
• ImmunoCellular Therapeutics Taps UPenn to Progress Mid-Stage Glioblastoma Candidate
  
• Plant-Based Protein Production System Developed
  
• Sanofi Pasteur Pays Vivalis €3M for Access to Human mAb Platform for Infectious Diseases
  
• Emergent Wins $107M Contract to Triple Anthrax Vaccine Production
  
• Medicago Wins $21M DARPA Award to Scale Up Production of Flu Vaccines
  
• Lonza Acquires Vivante to Expand into Viral-Based GMP Manufacturing
  
• GSK Obtains Rights to Delphi’s Antibiotic-Free Tech for Recombinant Vaccines
  
• Takeda Snags Exclusive License to Baxter’s Vero Cell Culture Tech for Flu Vaccine
  
• Beckman Coulter to Develop aNK Assay for Pivotal Trial of Transgene’s NSCLC Drug
  
• Soligenix Nabs Exclusive License to Vaccine Thermostabilization Technology
  
• Dutch Ministry Puts Public Vaccine Production Site up for Sale
  
• LGLS Licenses Novavax’ VLP Technology to Develop Flu Vaccines for South Korea and Other Emerging Markets
  
• Medicago Achieves $3.8M Milestone under DARPA Contract to Build Vaccine Plant
  
• Biovest and Ordway Research Institute to Evaluate Firm's Technology for Producing Virus-Fighting Products
  
• Northwest Biotherapeutics Signs on Fraunhofer IZI for Brain Cancer Vaccine Development
  
• Cevec Raises $8.5M to Commercialize Human Cell-Expression Platform for Proteins and Vaccines
  
• Sanofi Pasteur to Evaluate Leukocare’s Stabilization Technology for Vaccines
  
• GeoVax Receives Latest Tranche of $19.6M NIAID Funding for HIV Vaccine
  
• CSL Negotiates Option to Pevion’s Candida Vaccine for Australia and New Zealand